P.327 Withdrawal symptom assessment in an esketamine safety study in patients with treatment-resistant depression

Authors
Category Primary study
JournalEuropean Neuropsychopharmacology
Year 2019
This article has no abstract
Epistemonikos ID: 4b08903493860ca471ed59afa6ef2362ddfb9026
First added on: Feb 11, 2025